ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $240,000 | -44.3% | 5,789 | -19.9% | 0.15% | -45.0% |
| Q2 2022 | $431,000 | +46.6% | 7,231 | +78.8% | 0.27% | +83.0% |
| Q1 2022 | $294,000 | -25.2% | 4,044 | -13.5% | 0.15% | 0.0% |
| Q4 2021 | $393,000 | -6.9% | 4,677 | 0.0% | 0.15% | -10.9% |
| Q3 2021 | $422,000 | +17.2% | 4,677 | +23.8% | 0.16% | +19.6% |
| Q2 2021 | $360,000 | +7.1% | 3,777 | +27.9% | 0.14% | +0.7% |
| Q1 2021 | $336,000 | – | 2,952 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |